SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-17-001022
Filing Date
2017-03-13
Accepted
2017-03-13 16:54:24
Documents
62
Period of Report
2017-01-31

Document Format Files

Seq Description Document Type Size
1 c87730_10q.htm 10-Q 592146
2 c87730_ex31-1.htm EX-31.1 9370
3 c87730_ex31-2.htm EX-31.2 9371
4 c87730_ex32-1.htm EX-32.1 3889
5 c87730_ex32-2.htm EX-32.2 3816
  Complete submission text file 0000930413-17-001022.txt   3655292

Data Files

Seq Description Document Type Size
6 enz-20170131.xml EX-101.INS 767134
7 enz-20170131.xsd EX-101.SCH 49985
8 enz-20170131_cal.xml EX-101.CAL 42632
9 enz-20170131_def.xml EX-101.DEF 194536
10 enz-20170131_lab.xml EX-101.LAB 312835
11 enz-20170131_pre.xml EX-101.PRE 205078
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 17685783
SIC: 8071 Services-Medical Laboratories